LYG-409

CAT: 0804-HY-170952-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-170952-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
LYG-409 is an orally active degrader of GSPT1. LYG-409 shows excellent anti-acute myeloid leukemia and prostate cancer in vivo with TGI of 94.34% and 104.49%, respectively. LYG-409 inhibits KG-1 cells mediated by the degradation of GSPT1 with an IC50 of 9.50 nM, with a DC50 of 7.87 nM in vitro[1].
CAS Number
[3053857-55-6]
UNSPSC
12352005
Target
Molecular Glues
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.11
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1N(CC2=C1C=CC(CNC(C3=CC4=C(OC3)C=CC(OC(F)(F)F)=C4)=O)=C2)C5CCC(NC5=O)=O
Molecular Formula
C25H20F3N3O6
Molecular Weight
515.44
References & Citations
[1]Zhang Y, et al. Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders. J Med Chem. 2025 Feb 13;68 (3) :2608-2638.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-115436-01LYG-202
HY-P3304-01MR 409
HY-110057-01FR 409
HY-158113-01CBPD-409
HY-19090FK 409
HY-W999558CRBN ligand-409
HY-RI00918A-01Hsa-miR-409-5p antagomir
HY-RI00917A-01Hsa-miR-409-3p antagomir
HY-R00917-01Hsa-miR-409-3p mimic
HY-R00918-01Hsa-miR-409-5p mimic

Alternative Products

CatalogName
T205349-01LYG-409
A24461-10LYG-409 10mg
A24461-5LYG-409 5mg
A24461-50LYG-409 50mg
A24461-100LYG-409 100mg
sc-396595LYG-202
MBS5819693MR 409
T209572-01CBPD-409
A23966-1CBPD-409 1mg
A23966-5CBPD-409 5mg

Popular Products